Crossmark

Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Amblyomma cajennense (sensu lato) infestations of dogs

Crossref DOI link: https://doi.org/10.1186/s13071-018-3116-x

Published Online: 2018-10-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lasmar, Pedro Veloso Facury

Murphy, Martin

Nanchen, Steve

Drake, Jason http://orcid.org/0000-0001-6203-0852
Coumendouros, Katherina

Borges, Debora Azevedo

de Oliveira, Priscila Cardim

Scott, Fábio Barbour
Funding

Funding for this research was provided by:

Elanco Animal Health
License Information

Text and Data Mining valid from 2018-10-03
More Information

Article History

Received: 15 June 2018

Accepted: 18 September 2018

First Online: 3 October 2018

Ethics approval and consent to participate

: The protocol was approved by the Veterinary Institute of Universidade Federal Rural do Rio de Janeiro (UFRRJ) Animal Welfare Ethics Committee [Comissão de Ética no Uso de Animais (CEUA)] and by Novartis Animal Health Global Animal Welfare.

: Not applicable.

: PL, MM, SN and JD are employees of Elanco Animal Health.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.